Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...

Mirus offers solutions to increase process efficiency for viral vector production, and a unique reagent formulation that aims to boost virus quality and functional titres compared to traditional ...

Swiss drugmaker Novartis has opened a new viral vector production plant in Menges, central Slovenia, following an investment ...

At a recent meeting on viral vector purification held in Williamsburg ... Kleinschmidt, J.A. Novel tools for production and purification of recombinant adeno-associated virus vectors.

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

The Gene Vector Core was founded in 1997 as the Adenovirus Vector Production Core. Over the years, we have extended our expertise to other popular viral vector systems. Our core has been one of BCM ...

Creative Biolabs has expanded the viral vector production lines to enhance strategy and capabilities for genetic disorders and cancer research. SHIRLEY, NY, UNITED STATES, January 27, 2025 ...

Download this compendium from The Scientist’s Creative Services Team and Polyplus, now part of Sartorius, to learn more about viral vectors for gene therapy and discover how to enhance recombinant AAV ...

Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of partial species.

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint ...